Altman Advisors, Inc.

Position in NVS — Novartis AG

CIK 1731671 CHICAGO, IL

Position in NVS

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$2,334,501

+$47,681 QoQ

Shares Held

14,896

-0.5% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

1.03%

of 13F equity value

Holder Rank

#396

of 1,603 holders

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Altman Advisors, Inc. holds $13,882,576 across 5 Drug Manufacturers - General names. NVS ranks #5 (16.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	3,236	$3,881,355
2	GILD	Gilead Sciences, Inc.	21,931	$2,770,762
3	ABBV	AbbVie Inc.	9,733	$2,449,212
4	JNJ	Johnson & Johnson	9,634	$2,446,746
5	NVS	Novartis AG This page	14,896	$2,334,501

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,334,501	14,896	-0.5%	Shares	Sole	2026-08-11
2026-03-31	$2,286,820	14,971	-12.5%	Shares	Sole	2026-05-05
2025-12-31	$2,359,231	17,112	-0.1%	Shares	Sole	2026-02-04
2025-09-30	$2,197,520	17,136	+0.8%	Shares	Sole	2025-11-13
2025-06-30	$2,057,170	17,000	+3.3%	Shares	Sole	2025-08-07
2025-03-31	$1,834,180	16,453	+3.2%	Shares	Sole	2025-05-02
2024-12-31	$1,551,510	15,944	+1.8%	Shares	Sole	2025-02-13
2024-09-30	$1,800,753	15,656	+0.6%	Shares	Sole	2024-11-08
2024-06-30	$1,657,156	15,566	+0.3%	Shares	Sole	2024-08-08
2024-03-31	$1,500,862	15,516	+3.9%	Shares	Sole	2024-05-09
2023-12-31	$1,507,885	14,934	+1.5%	Shares	Sole	2024-02-08
2023-09-30	$1,499,073	14,717	+0.1%	Shares	Sole	2023-11-14
2023-03-31	$1,353,228	14,709	—	Shares	Sole	2023-05-09
No filing history on record for this holder in this stock.